These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8198867)

  • 1. Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells.
    Reinhardt B; Torbett BE; Gulizia RJ; Reinhardt PP; Spector SA; Mosier DE
    AIDS Res Hum Retroviruses; 1994 Feb; 10(2):131-41. PubMed ID: 8198867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Simple Mouse Model for the Study of Human Immunodeficiency Virus.
    Kim KC; Choi BS; Kim KC; Park KH; Lee HJ; Cho YK; Kim SI; Kim SS; Oh YK; Kim YB
    AIDS Res Hum Retroviruses; 2016 Feb; 32(2):194-202. PubMed ID: 26564392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of human immunodeficiency virus type 1 replication in human xenografts of acutely infected Hu-PBL-SCID mice.
    Koup RA; Hesselton RM; Safrit JT; Somasundaran M; Sullivan JL
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):279-84. PubMed ID: 8018388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S; Lapenta C; Santini SM; Spada M; Parlato S; Logozzi M; Rizza P; Belardelli F
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain.
    Koyanagi Y; Tanaka Y; Kira J; Ito M; Hioki K; Misawa N; Kawano Y; Yamasaki K; Tanaka R; Suzuki Y; Ueyama Y; Terada E; Tanaka T; Miyasaka M; Kobayashi T; Kumazawa Y; Yamamoto N
    J Virol; 1997 Mar; 71(3):2417-24. PubMed ID: 9032379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
    Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P; Santini SM; Logozzi MA; Lapenta C; Sestili P; Gherardi G; Lande R; Spada M; Parlato S; Belardelli F; Fais S
    J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
    Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
    J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
    Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
    J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
    Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
    J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
    Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
    Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model.
    Autran B; Guiet P; Raphael M; Grandadam M; Agut H; Candotti D; Grenot P; Puech F; Debre P; Cesbron JY
    AIDS; 1996 Jun; 10(7):717-27. PubMed ID: 8805862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
    Cao T; Lazdina U; Desombere I; Vanlandschoot P; Milich DR; Sällberg M; Leroux-Roels G
    J Virol; 2001 Jul; 75(14):6359-66. PubMed ID: 11413302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.
    Miura Y; Misawa N; Maeda N; Inagaki Y; Tanaka Y; Ito M; Kayagaki N; Yamamoto N; Yagita H; Mizusawa H; Koyanagi Y
    J Exp Med; 2001 Mar; 193(5):651-60. PubMed ID: 11238596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
    Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human immunodeficiency virus infection of human-PBL-SCID mice.
    Mosier DE; Gulizia RJ; Baird SM; Wilson DB; Spector DH; Spector SA
    Science; 1991 Feb; 251(4995):791-4. PubMed ID: 1990441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.